Sanford, NC, site adds clinical, commercial production capacity as company expands its pipeline
Astellas Gene Therapies has raised its investment in gene therapy development—and it hopes, positioned itself for future success in the specialty—by opening a $100 million manufacturing facility in Sanford, NC. The new site comes online two and a half years after Astellas expanded its primary focus areas to include gene therapy through its $3 billion acquisition of Audentes Therapeutics [Astellas Pharma]
The new 135,000-square-foot gene therapy facility, at 6074 Enterprise Park Drive within Central Carolina Enterprise Park, opened with an initial capacity of 4,000 liters of production. The site is designed for future expansion within its walls to accommodate an additional 16,000 liters of capacity—a potential for expansion Astellas lacks in South San Francisco, a site that also has a capacity of 4,000 liters . . .
